Humacyte, Inc. (NASDAQ:HUMAW – Get Free Report)’s stock price fell 0.3% on Friday . The stock traded as low as $2.80 and last traded at $3.08. 30,392 shares traded hands during mid-day trading, an increase of 4% from the average session volume of 29,217 shares. The stock had previously closed at $3.09.
Humacyte Stock Down 0.3 %
The company’s 50 day moving average price is $2.22 and its two-hundred day moving average price is $1.24.
Humacyte Company Profile
Humacyte, Inc engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular vessels (HAVs) to be implanted into patient without inducing a foreign body response or leading to immune rejection.
Featured Articles
- Five stocks we like better than Humacyte
- Stock Market Upgrades: What Are They?
- Market Crash? No Problem for DoorDash Stock’s Impressive Earnings
- What is a Bond Market Holiday? How to Invest and Trade
- Snap’s Stock Plummets on Q2 Revenue Guidance Shortfall
- Are Penny Stocks a Good Fit for Your Portfolio?
- Hims & Hers Stock Falls on DexCom Fears: Analysts Predict Rally
Receive News & Ratings for Humacyte Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humacyte and related companies with MarketBeat.com's FREE daily email newsletter.
